A detailed history of Platinum Investment Management LTD transactions in Centogene N.V. stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,186,102 shares of CNTG stock, worth $474,440. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,186,102
Previous 2,376,442 50.09%
Holding current value
$474,440
Previous $2.85 Million 70.47%
% of portfolio
0.03%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.65 - $1.25 $773,721 - $1.49 Million
-1,190,340 Reduced 50.09%
1,186,102 $842,000
Q4 2023

Feb 13, 2024

SELL
$1.02 - $1.47 $722 - $1,040
-708 Reduced 0.03%
2,376,442 $2.85 Million
Q3 2022

Nov 14, 2022

BUY
$1.21 - $2.78 $128,260 - $294,680
106,000 Added 4.67%
2,377,150 $2.66 Million
Q2 2022

Aug 11, 2022

SELL
$2.06 - $4.25 $12,360 - $25,500
-6,000 Reduced 0.26%
2,271,150 $5.38 Million
Q4 2021

Feb 11, 2022

BUY
$4.56 - $10.56 $1.61 Million - $3.74 Million
354,065 Added 18.41%
2,277,150 $11.9 Million
Q3 2021

Nov 09, 2021

BUY
$9.9 - $11.72 $2.56 Million - $3.03 Million
258,413 Added 15.52%
1,923,085 $21.2 Million
Q2 2021

Aug 11, 2021

BUY
$9.02 - $12.93 $11 Million - $15.8 Million
1,220,077 Added 274.42%
1,664,672 $17.4 Million
Q1 2021

May 13, 2021

BUY
$10.56 - $13.94 $371,785 - $490,785
35,207 Added 8.6%
444,595 $5.39 Million
Q4 2020

Feb 12, 2021

BUY
$9.44 - $13.3 $327,501 - $461,416
34,693 Added 9.26%
409,388 $4.41 Million
Q3 2020

Nov 13, 2020

BUY
$9.3 - $25.16 $2.94 Million - $7.94 Million
315,615 Added 534.22%
374,695 $3.55 Million
Q2 2020

Aug 06, 2020

BUY
$15.99 - $22.88 $944,689 - $1.35 Million
59,080 New
59,080 $1.35 Million

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $10.8M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.